Clinical Social Workers in Paradise Valley, AZ Accepting Medicare
3 Clinical Social Workers found. Showing 1 - 3
 Dr. Joseph Dillard, LCSW, PHD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7825 N Invergordon Pl, Paradise Valley, AZ 85253 Phone: 480-951-8539 Fax: 602-224-0010 |
 Margaret Borden, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6947 E Mcdonald Dr, Paradise Valley, AZ 85253 Phone: 480-991-4267 |
Mr. Michael Asher Gentry, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7101 E Orange Blossom Ln, Paradise Valley, AZ 85253 Phone: 832-746-3847 |
News Archive
If there's no deficit reduction deal, what happens next?
Both parties are jockeying for position, trying to spin the super committee's expected announcement of failure into political victory. Meanwhile, some news outlets are examining what happens next for the automatic cuts, which will be triggered in 2013 if the deficit panel indeed does not offer a plan.
Increased growth factor protects retinal blood vessels in animal models with diabetes
Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease.
Major CIHR grant to help find and tackle the root cause of neurodegenerative disease
Dr. Simonetta Sipione, GlycoNet Investigator and Professor in the Department of Pharmacology at the University of Alberta, was recently awarded a major five-year grant from the Canadian Institutes of Health Research, worth $1.04 million.
Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global Phase 2/3 study with opaganib (Yeliva, ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840).
Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.
› Verified 6 days ago
Dentists
Pharmacists
Psychologists
Clinical Social Workers
Counselors